Clinical Trial Results

Eli Lilly posts results of all Lilly-sponsored phase II, phase III and phase IV clinical trials of Lilly marketed products conducted anywhere in the world that were initiated on or after October 15, 2002. This section links to phase II, phase III and phase IV results posted as CTR Summaries on ClinicalStudyResults.org and/or as CTR Results Record data tables on ClinicalTrials.gov.

Results are in the ICH-E3 synopsis summary format for trials that completed prior to December 8, 2007.

Results are in the Results Record data table format for trials that completed on or after September 27, 2007.

ClinicalStudyResults.org contains a search function. Users can find specific information based on company name, disease, drug name, study identifier, etc.

ClinicalTrials.gov contains a search function. Users can find specific information based on trial parameters such as condition, intervention, location, sponsor, phase, study identifiers, recruitment status, etc.

Summaries/data tables of clinical study results are intended to report the results of the study that were known at the time of each study's completion. The information contained in these summaries/data tables is not intended to promote or otherwise commercialize (directly or indirectly) any off-label or unapproved uses of Lilly medicines, nor is it intended to provide a comprehensive analysis of all data currently available regarding a particular drug. In some cases, more current information regarding a drug, including post-hoc analyses and meta-analyses, may be available as part of the general body of scientific knowledge in forms such as manuscripts, abstracts, or posters.

Note that clinical studies on Lilly products may also be sponsored and reported by parties other than Lilly in other clinical trial registries.